ArticleStem cells translational medicine2026

Five-year follow-up outcomes after phase 1 trial of mesenchymal stromal cells for periventricular hemorrhagic infarction in preterm infants.

Misun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.